Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775267 · ClinicalTrials.gov registry record · Phase 2
ALLPS VERSUS PVO Randomized Controlled Trial
A Phase 2 study, sponsored by University of Zurich.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01775267: Clinical Trial Phase 2 study, sponsored by University of Zurich.
NCT01775267 is a Phase 2 study that was terminated before completion, run by University of Zurich. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01775267, a Phase 2 study, was terminated before completion, sponsored by University of Zurich.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable. * Trial with surgical intervention
Interventions
- PROCEDURE Associating liver partition and portal vein ligation for staged hepatectomy
- PROCEDURE Portal vein embolization or ligation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
| Phase | Phase 2 |
Why NCT01775267 stopped before completion
NCT01775267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Associating liver partition and portal vein ligation for staged hepatectomy is the first listed.
NCT01775267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01775267 about?
NCT01775267 is a clinical study titled "ALLPS VERSUS PVO Randomized Controlled Trial". This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may b...
What is the current status of trial NCT01775267?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01775267?
The interventions under investigation include: Associating liver partition and portal vein ligation for staged hepatectomy (PROCEDURE), Portal vein embolization or ligation (PROCEDURE).
Who is sponsoring clinical trial NCT01775267?
This trial is sponsored by University of Zurich, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01775267's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia